BASE life science A/S — Credit Rating and Financial Key Figures

CVR number: 30906942
Lyngbyvej 2, 2100 København Ø
contact@baselifescience.com
tel: 88202120
www.baselifescience.com
Free credit reportSee consolidated company

Income statement (kDKK)

2019
2020
2021
2022
2023
Fiscal period length1212121212
Net sales
Gross profit65 461.4793 829.70117 471.3484 927.8093 372.44
Employee benefit expenses-49 484.28-76 910.38-92 369.85- 147 348.71- 153 668.59
Total depreciation-88.67- 138.38- 903.57-2 849.63-3 717.12
EBIT15 888.5216 780.9524 197.92-65 270.54-64 013.27
Other financial income6.98109.67243.3560.43160.64
Other financial expenses- 121.27- 280.54- 447.27- 528.25-3 556.89
Net income from associates (fin.)6 435.5934 479.08-20 514.63
Pre-tax profit15 774.2316 610.0830 429.59-31 259.28-87 924.15
Income taxes-3 472.77-2 848.17-6 234.7935.003.04
Net earnings12 301.4613 761.9124 194.81-31 224.29-87 921.12

Assets (kDKK)

2019
2020
2021
2022
2023
Development expenditure4 123.264 824.693 859.752 894.81
Intangible rights83.0765.27
Intangible assets total4 123.264 824.693 942.822 960.08
Machinery and equipment135.98460.293 081.773 907.502 769.52
Tangible assets total135.98460.293 081.773 907.502 769.52
Holdings in group member companies700.00886.2410 596.2244 800.4225 919.15
Other receivables466.72468.92925.201 051.811 265.89
Investments total1 166.721 355.1611 521.4145 852.2327 185.04
Long term receivables total
Inventories total
Current trade debtors22 624.4630 769.9966 635.9743 722.6753 601.02
Current amounts owed by group member comp.1 420.511 520.868 203.8622 060.9320 491.15
Current owed by particip. interest comp.172.12
Prepayments and accrued income155.72392.254 062.732 464.544 118.87
Current other receivables1 436.268 012.337 545.7428 400.4032 273.38
Current deferred tax assets3.79921.39767.00
Short term receivables total25 640.7441 616.8186 448.2996 820.65111 251.42
Cash and bank deposits10 824.606 597.92114.274 123.4011 804.35
Cash and cash equivalents10 824.606 597.92114.274 123.4011 804.35
Balance sheet total (assets)37 768.0454 153.44105 990.43154 646.60155 970.41

Equity and liabilities (kDKK)

2019
2020
2021
2022
2023
Share capital600.00600.00600.00597.40597.40
Shares repurchased2 700.002 109.00
Other reserves4 123.2613 235.5646 612.5425 345.25
Retained earnings3 045.485 575.1812 184.905 510.58-4 234.13
Profit of the financial year12 301.4613 761.9124 194.81-31 224.29-87 921.12
Shareholders equity total18 646.9426 169.3550 215.2721 496.23-66 212.60
Provisions1 250.001 265.271 017.99802.66
Non-current loans from credit institutions1 923.29
Non-current owed to group member97 379.54
Non-current other liabilities2 818.25
Non-current liabilities total2 818.251 923.2997 379.54
Current loans from credit institutions168.50110.683 063.09347.65589.27
Advances received1 039.34256.35947.682 389.61
Current trade creditors2 368.473 772.8022 052.0362 424.4857 535.18
Current owed to participating513.06513.06
Current owed to group member4 037.214 358.09
Short-term deferred tax liabilities3 338.043 451.767 938.332 982.57
Other non-interest bearing current liabilities8 951.4116 470.7819 995.7259 950.8761 518.26
Accruals and deferred income437.09235.36
Current liabilities total16 302.8524 810.8054 509.90132 132.39124 000.81
Balance sheet total (liabilities)37 768.0454 153.44105 990.43154 646.60155 970.41
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.

Full version